Back to article: Metabolic and functional reprogramming of myeloid-derived suppressor cells and their therapeutic control in glioblastoma

FIGURE 3: Therapeutic approaches to block the growth and immunosuppressive functions of MDSCs for glioblastoma treatment. The survival and immune functions of MDSCs can be controlled by various strategies such as targeting metabolic pathways, checkpoint inhibition, depletion of MDSCs, or blocking other functions such as proliferation and migration of MDSCs into the TME in several mouse glioma models and clinical trial studies for human glioblastoma patients.

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this. Please refer to our "privacy statement" and our "terms of use" for further information.